543 related articles for article (PubMed ID: 9190923)
1. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
3. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
4. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
Söderström K; Corliss B; Lanier LL; Phillips JH
J Immunol; 1997 Aug; 159(3):1072-5. PubMed ID: 9233599
[TBL] [Abstract][Full Text] [Related]
5. How do NK cells sense the expression of HLA-G class Ib molecules?
López-Botet M; Navarro F; Llano M
Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
[TBL] [Abstract][Full Text] [Related]
6. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
[TBL] [Abstract][Full Text] [Related]
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
8. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
9. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
[TBL] [Abstract][Full Text] [Related]
10. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
Vance RE; Tanamachi DM; Hanke T; Raulet DH
Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
[TBL] [Abstract][Full Text] [Related]
11. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell-mediated recognition of human trophoblast.
Biassoni R; Bottino C; Millo R; Moretta L; Moretta A
Semin Cancer Biol; 1999 Feb; 9(1):13-8. PubMed ID: 10092546
[TBL] [Abstract][Full Text] [Related]
13. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
14. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.
Lazetic S; Chang C; Houchins JP; Lanier LL; Phillips JH
J Immunol; 1996 Dec; 157(11):4741-5. PubMed ID: 8943374
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
[TBL] [Abstract][Full Text] [Related]
16. Natural killer clones recognize specific soluble HLA class I molecules.
Carbone E; Terrazzano G; Colonna M; Tuosto L; Piccolella E; Franksson L; Palazzolo G; Pérez-Villar JJ; Fontana S; Kärre K; Zappacosta S
Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
[TBL] [Abstract][Full Text] [Related]
17. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
[TBL] [Abstract][Full Text] [Related]
18. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
[TBL] [Abstract][Full Text] [Related]
19. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
Ding Y; Sumitran S; Holgersson J
Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules.
Sivori S; Vitale M; Sanseverino L; Parolini S; Barbaresi M; Bottino C; Moretta A
Transplant Proc; 1996 Dec; 28(6):3199-203. PubMed ID: 8962240
[No Abstract] [Full Text] [Related]
[Next] [New Search]